Upper gastrointestinal tract microbiota with oral origin in relation to oesophageal squamous cell carcinoma

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):1–20. doi: 10.3322/caac.21492.
   Web of Science ®Google Scholar
• Abnet CC, Arnold M, Wei WQ. Epidemiology of esophageal squamous cell carcinoma. Gastroenterology. 2018;154(2):360–373. doi: 10.1053/j.gastro.2017.08.023.
   PubMed Web of Science ®Google Scholar
• Qi YJ, Chao WX, Chiu JF. An overview of esophageal squamous cell carcinoma proteomics. J Proteomics. 2012;75(11):3129–3137. doi: 10.1016/j.jprot.2012.04.025.
   PubMed Web of Science ®Google Scholar
• Yang CX, Wang HY, Wang ZM, et al. Risk factors for esophageal cancer: a case-control study in South-Western China. Asian Pacific J Cancer Prevent: APJCP. 2005;6(1):48–53.
   PubMedGoogle Scholar
• Siassi F, Ghadirian P. Riboflavin deficiency and esophageal cancer: a case control-household study in the caspian Littoral of Iran. Cancer Detect Prev. 2005;29(5):464–469. doi: 10.1016/j.cdp.2005.08.001.
   PubMedGoogle Scholar
• Sun G, Wang S, Hu X, et al. Fumonisin B1 contamination of home-grown corn in high-risk areas for esophageal and liver cancer in China. Food Addit Contam. 2007;24(2):181–185. doi: 10.1080/02652030601013471.
   PubMed Web of Science ®Google Scholar
• Wang LD, Zhou FY, Li XM, et al. Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies susceptibility loci at PLCE1 and C20orf54. Nat Genet. 2010;42(9):759–763. doi: 10.1038/ng.648.
   PubMed Web of Science ®Google Scholar
• Morita M, Kumashiro R, Kubo N, et al. Alcohol drinking, cigarette smoking, and the development of squamous cell carcinoma of the esophagus: epidemiology, clinical findings, and prevention. Int J Clin Oncol. 2010;15(2):126–134. doi: 10.1007/s10147-010-0056-7.
   PubMed Web of Science ®Google Scholar
• Engel LS, Chow WH, Vaughan TL, et al. Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst. 2003;95(18):1404–1413. doi: 10.1093/jnci/djg047.
   PubMed Web of Science ®Google Scholar
• Southerland JH, Taylor GW, Moss K, et al. Commonality in chronic inflammatory diseases: periodontitis, diabetes, and coronary artery disease. Periodontol 2000. 2006;40(1):130–143. doi: 10.1111/j.1600-0757.2005.00138.x.
   PubMedGoogle Scholar
• Teng YT, Taylor GW, Scannapieco F, et al. Periodontal health and systemic disorders. J Canadian Dental Assoc. 2002;68(3):188–192.
   PubMedGoogle Scholar
• Beck JD, Offenbacher S. Systemic effects of periodontitis: epidemiology of periodontal disease and cardiovascular disease. J Periodontol. 2005;76(11 Suppl):2089–2100. doi: 10.1902/jop.2005.76.11-S.2089.
   Web of Science ®Google Scholar
• Pihlstrom BL, Michalowicz BS, Johnson NW. Periodontal diseases. Lancet. 2005;366(9499):1809–1820. doi: 10.1016/S0140-6736(05)67728-8.
   PubMed Web of Science ®Google Scholar
• Nwizu NN, Marshall JR, Moysich K, et al. Periodontal disease and incident cancer risk among postmenopausal women: results from the women’s health initiative observational cohort. Cancer Epidemiol Biomarkers Prev. 2017;26(8):1255–1265. doi: 10.1158/1055-9965.EPI-17-0212.
   PubMed Web of Science ®Google Scholar
• Meyer MS, Joshipura K, Giovannucci E, et al. A review of the relationship between tooth loss, periodontal disease, and cancer. Cancer Causes Control. 2008;19(9):895–907. doi: 10.1007/s10552-008-9163-4.
   PubMed Web of Science ®Google Scholar
• Michaud DS, Liu Y, Meyer M, et al. Periodontal disease, tooth loss, and cancer risk in male health professionals: a prospective cohort study. Lancet Oncol. 2008;9(6):550–558. doi: 10.1016/S1470-2045(08)70106-2.
   PubMed Web of Science ®Google Scholar
• Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420(6917):860–867. doi: 10.1038/nature01322.
   PubMed Web of Science ®Google Scholar
• Balkwill F, Mantovani A. Inflammation and cancer: back to virchow? Lancet. 2001;357(9255):539–545. doi: 10.1016/S0140-6736(00)04046-0.
   PubMed Web of Science ®Google Scholar
• Allavena P, Garlanda C, Borrello MG, et al. Pathways connecting inflammation and cancer. Curr Opin Genet Dev. 2008;18(1):3–10. doi: 10.1016/j.gde.2008.01.003.
   PubMed Web of Science ®Google Scholar
• Trinchieri G. Cancer and inflammation: an old intuition with rapidly evolving new concepts. Annu Rev Immunol. 2012;30(1):677–706. doi: 10.1146/annurev-immunol-020711-075008.
   PubMedGoogle Scholar
• Schetter AJ, Heegaard NH, Harris CC. Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways. Carcinogenesis. 2010;31(1):37–49. doi: 10.1093/carcin/bgp272.
   PubMed Web of Science ®Google Scholar
• Lin WW, Karin M. A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest. 2007;117(5):1175–1183. doi: 10.1172/JCI31537.
   PubMed Web of Science ®Google Scholar
• Hattori N, Ushijima T. Epigenetic impact of infection on carcinogenesis: mechanisms and applications. Genome Med. 2016;8(1):10. doi: 10.1186/s13073-016-0267-2.
   PubMedGoogle Scholar
• Nardone G, Compare D, Rocco A. A microbiota-centric view of diseases of the upper gastrointestinal tract. Lancet Gastroenterol Hepatol. 2017;2(4):298–312. doi: 10.1016/S2468-1253(16)30108-X.
   PubMed Web of Science ®Google Scholar
• Ley RE, Turnbaugh PJ, Klein S, et al. Microbial ecology: human gut microbes associated with obesity. Nature. 2006;444(7122):1022–1023. doi: 10.1038/4441022a.
   PubMed Web of Science ®Google Scholar
• Hooper LV, Gordon JI. Commensal host-bacterial relationships in the gut. Science. 2001;292(5519):1115–1118. doi: 10.1126/science.1058709.
   PubMed Web of Science ®Google Scholar
• Sartor RB. Microbial influences in inflammatory bowel diseases. Gastroenterology. 2008;134(2):577–594. doi: 10.1053/j.gastro.2007.11.059.
   PubMed Web of Science ®Google Scholar
• Tözün N, Vardareli E, Proceedings from the 8th Probiotics, Prebiotics & New Foods for Microbiota and Human Health meeting held in Rome, Italy on September 13-15, 2015. Gut microbiome and gastrointestinal cancer: les liaisons dangereuses. J Clin Gastroenterol. 2016;50 Suppl 2, Proceedings from the 8th Probiotics, Prebiotics & New Foods for Microbiota and Human Health meeting held in Rome, Italy on September 13-15, 2015Suppl(Supplement 2):S191–s196. doi: 10.1097/MCG.0000000000000714.
   Google Scholar
• Chen X, Yuan Z, Lu M, et al. Poor oral health is associated with an increased risk of esophageal squamous cell carcinoma - a population-based case-control study in China. Int J Cancer. 2017;140(3):626–635. doi: 10.1002/ijc.30484.
   PubMed Web of Science ®Google Scholar
• Abnet CC, Qiao YL, Mark SD, et al. Prospective study of tooth loss and incident esophageal and gastric cancers in China. Cancer Causes Control. 2001;12(9):847–854. doi: 10.1023/a:1012290009545.
   PubMed Web of Science ®Google Scholar
• Dar NA, Islami F, Bhat GA, et al. Poor oral hygiene and risk of esophageal squamous cell carcinoma in Kashmir. Br J Cancer. 2013;109(5):1367–1372. doi: 10.1038/bjc.2013.437.
   PubMed Web of Science ®Google Scholar
• Abnet CC, Kamangar F, Islami F, et al. Tooth loss and lack of regular oral hygiene are associated with higher risk of esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 2008;17(11):3062–3068. doi: 10.1158/1055-9965.EPI-08-0558.
   PubMed Web of Science ®Google Scholar
• Guha N, Boffetta P, Wünsch Filho V, et al. Oral health and risk of squamous cell carcinoma of the head and neck and esophagus: results of two multicentric case-control studies. Am J Epidemiol. 2007;166(10):1159–1173. doi: 10.1093/aje/kwm193.
   PubMed Web of Science ®Google Scholar
• Sato F, Oze I, Kawakita D, et al. Inverse association between toothbrushing and upper aerodigestive tract cancer risk in a Japanese population. Head Neck. 2011;33(11):1628–1637. doi: 10.1002/hed.21649.
   PubMed Web of Science ®Google Scholar
• Wang YP, Han XY, Su W, et al. Esophageal cancer in Shanxi province, people’s republic of China: a case-control study in high and moderate risk areas. Cancer Causes Control. 1992;3(2):107–113. doi: 10.1007/BF00051650.
   PubMed Web of Science ®Google Scholar
• Darveau RP. Periodontitis: a polymicrobial disruption of host homeostasis. Nat Rev Microbiol. 2010;8(7):481–490. doi: 10.1038/nrmicro2337.
   PubMed Web of Science ®Google Scholar
• Hiraki A, Matsuo K, Suzuki T, et al. Teeth loss and risk of cancer at 14 common sites in Japanese. Cancer Epidemiol Biomarkers Prev. 2008;17(5):1222–1227. doi: 10.1158/1055-9965.EPI-07-2761.
   PubMed Web of Science ®Google Scholar
• Nasrollahzadeh D, Malekzadeh R, Aghcheli K, et al. Gastric atrophy and oesophageal squamous cell carcinoma: possible interaction with dental health and oral hygiene habit. Br J Cancer. 2012;107(5):888–894. doi: 10.1038/bjc.2012.332.
   PubMed Web of Science ®Google Scholar
• Abnet CC, Kamangar F, Dawsey SM, et al. Tooth loss is associated with increased risk of gastric non-cardia adenocarcinoma in a cohort of Finnish smokers. Scand J Gastroenterol. 2005;40(6):681–687. doi: 10.1080/00365520510015430.
   PubMed Web of Science ®Google Scholar
• Sepehr A, Kamangar F, Fahimi S, et al. Poor oral health as a risk factor for esophageal squamous dysplasia in northeastern Iran. Anticancer Res. 2005;25(1b):543–546.
   PubMed Web of Science ®Google Scholar
• Papapanou PN. Periodontal diseases: epidemiology. Ann Periodontol. 1996;1(1):1–36. doi: 10.1902/annals.1996.1.1.1.
   PubMedGoogle Scholar
• Irfan UM, Dawson DV, Bissada NF. Epidemiology of periodontal disease: a review and clinical perspectives. J Int Acad Periodontol. 2001;3(1):14–21.
   PubMedGoogle Scholar
• Tonetti MS, Van Dyke TE, working group 1 of the joint EFP/AAP workshop. Periodontitis and atherosclerotic cardiovascular disease: consensus report of the joint EFP/AAP workshop on periodontitis and systemic diseases. J Periodontol. 2013;84(4 Suppl):S24–S29. doi: 10.1902/jop.2013.1340019.
   PubMed Web of Science ®Google Scholar
• Oringer RJ. Modulation of the host response in periodontal therapy. J Periodontol. 2002;73(4):460–470.
   PubMed Web of Science ®Google Scholar
• Baima G, Muwalla M, Testa G, et al. Periodontitis prevalence and severity in inflammatory bowel disease: a case-control study. J Periodontol. 2023;94(3):313–322. doi: 10.1002/JPER.22-0322.
   PubMed Web of Science ®Google Scholar
• Sung CE, Lin FG, Huang RY, et al. Periodontitis, Helicobacter pylori infection, and gastrointestinal tract cancer mortality. J Clin Periodontol. 2022;49(3):210–220. doi: 10.1111/jcpe.13590.
   PubMed Web of Science ®Google Scholar
• Fan X, Alekseyenko AV, Wu J, et al. Human oral microbiome and prospective risk for pancreatic cancer: a population-based nested case-control study. Gut. 2018;67(1):120–127. doi: 10.1136/gutjnl-2016-312580.
   PubMed Web of Science ®Google Scholar
• Wen BW, Tsai CS, Lin CL, et al. Cancer risk among gingivitis and periodontitis patients: a nationwide cohort study. QJM. 2014;107(4):283–290. doi: 10.1093/qjmed/hct248.
   PubMed Web of Science ®Google Scholar
• Chou SH, Tung YC, Wu LS, et al. Severity of chronic periodontitis and risk of gastrointestinal cancers: a population-based follow-up study from Taiwan. Medicine (Baltimore). 2018;97(27):e11386. doi: 10.1097/MD.0000000000011386.
   PubMed Web of Science ®Google Scholar
• Dewhirst FE, Chen T, Izard J, et al. The human oral microbiome. J Bacteriol. 2010;192(19):5002–5017. doi: 10.1128/JB.00542-10.
   PubMed Web of Science ®Google Scholar
• Kudo Y, Tada H, Fujiwara N, et al. Oral environment and cancer. Genes Environ. 2016;38(1):13. doi: 10.1186/s41021-016-0042-z.
   PubMedGoogle Scholar
• Zhang Y, Niu Q, Fan W, et al. Oral microbiota and gastrointestinal cancer. Onco Targets Ther. 2019;12:4721–4728. doi: 10.2147/OTT.S194153.
   PubMed Web of Science ®Google Scholar
• Hajishengallis G, Lamont RJ. Beyond the red complex and into more complexity: the polymicrobial synergy and dysbiosis (PSD) model of periodontal disease etiology. Mol Oral Microbiol. 2012;27(6):409–419. doi: 10.1111/j.2041-1014.2012.00663.x.
   PubMed Web of Science ®Google Scholar
• Amodini Rajakaruna G, Umeda M, Uchida K, et al. Possible translocation of periodontal pathogens into the lymph nodes draining the oral cavity. J Microbiol. 2012;50(5):827–836. doi: 10.1007/s12275-012-2030-8.
   PubMed Web of Science ®Google Scholar
• El-Solh AA, Pietrantoni C, Bhat A, et al. Microbiology of severe aspiration pneumonia in institutionalized elderly. Am J Respir Crit Care Med. 2003;167(12):1650–1654. doi: 10.1164/rccm.200212-1543OC.
   PubMed Web of Science ®Google Scholar
• Gaetti-Jardim E, Jr., Marcelino SL, Feitosa AC, et al. Quantitative detection of periodontopathic bacteria in atherosclerotic plaques from coronary arteries. J Med Microbiol. 2009;58(Pt 12):1568–1575. doi: 10.1099/jmm.0.013383-0.
   PubMed Web of Science ®Google Scholar
• Ford PJ, Gemmell E, Chan A, et al. Inflammation, heat shock proteins and periodontal pathogens in atherosclerosis: an immunohistologic study. Oral Microbiol Immunol. 2006;21(4):206–211. doi: 10.1111/j.1399-302X.2006.00276.x.
   PubMedGoogle Scholar
• Salazar CR, Sun J, Li Y, et al. Association between selected oral pathogens and gastric precancerous lesions. PLoS One. 2013;8(1):e51604. doi: 10.1371/journal.pone.0051604.
   PubMed Web of Science ®Google Scholar
• Kostic AD, Chun E, Robertson L, et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe. 2013;14(2):207–215. doi: 10.1016/j.chom.2013.07.007.
   PubMed Web of Science ®Google Scholar
• Narikiyo M, Tanabe C, Yamada Y, et al. Frequent and preferential infection of Treponema denticola, Streptococcus mitis, and Streptococcus anginosus in esophageal cancers. Cancer Sci. 2004;95(7):569–574. doi: 10.1111/j.1349-7006.2004.tb02488.x.
   PubMed Web of Science ®Google Scholar
• Gao S, Li S, Ma Z, et al. Presence of Porphyromonas gingivalis in esophagus and its association with the clinicopathological characteristics and survival in patients with esophageal cancer. Infect Agent Cancer. 2016;11(1):3. doi: 10.1186/s13027-016-0049-x.
   PubMedGoogle Scholar
• Yamamura K, Baba Y, Nakagawa S, et al. Human microbiome Fusobacterium Nucleatum in esophageal cancer tissue is associated with prognosis. Clin Cancer Res. 2016;22(22):5574–5581. doi: 10.1158/1078-0432.CCR-16-1786.
   PubMed Web of Science ®Google Scholar
• Yamamura K, Izumi D, Kandimalla R, et al. Intratumoral Fusobacterium Nucleatum levels predict therapeutic response to neoadjuvant chemotherapy in esophageal squamous cell carcinoma. Clin Cancer Res. 2019;25(20):6170–6179. doi: 10.1158/1078-0432.CCR-19-0318.
   PubMed Web of Science ®Google Scholar
• Kostic AD, Gevers D, Pedamallu CS, et al. Genomic analysis identifies association of fusobacterium with colorectal carcinoma. Genome Res. 2012;22(2):292–298. doi: 10.1101/gr.126573.111.
   PubMed Web of Science ®Google Scholar
• Castellarin M, Warren RL, Freeman JD, et al. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res. 2012;22(2):299–306. doi: 10.1101/gr.126516.111.
   PubMed Web of Science ®Google Scholar
• Yu T, Guo F, Yu Y, et al. Fusobacterium nucleatum promotes chemoresistance to colorectal cancer by modulating autophagy. Cell. 2017;170(3):548–563.e516. doi: 10.1016/j.cell.2017.07.008.
   PubMed Web of Science ®Google Scholar
• Norder Grusell E, Dahlén G, Ruth M, et al. Bacterial flora of the human oral cavity, and the upper and lower esophagus. Dis Esophagus. 2013;26(1):84–90. doi: 10.1111/j.1442-2050.2012.01328.x.
   PubMed Web of Science ®Google Scholar
• Okereke I, Hamilton C, Reep G, et al. Microflora composition in the gastrointestinal tract in patients with Barrett’s esophagus. J Thorac Dis. 2019;11(Suppl 12):S1581–s1587. doi: 10.21037/jtd.2019.06.15.
   PubMedGoogle Scholar
• Chen X, Winckler B, Lu M, et al. Oral microbiota and risk for esophageal squamous cell carcinoma in a high-risk area of China. PLoS One. 2015;10(12):e0143603. doi: 10.1371/journal.pone.0143603.
   PubMed Web of Science ®Google Scholar
• Wen L, Mu W, Lu H, et al. Porphyromonas gingivalis promotes oral squamous cell carcinoma progression in an immune microenvironment. J Dent Res. 2020;99(6):666–675. doi: 10.1177/0022034520909312.
   PubMed Web of Science ®Google Scholar
• Peters BA, Wu J, Pei Z, et al. Oral microbiome composition reflects prospective risk for esophageal cancers. Cancer Res. 2017;77(23):6777–6787. doi: 10.1158/0008-5472.CAN-17-1296.
   PubMed Web of Science ®Google Scholar
• Gagliardi D, Makihara S, Corsi PR, et al. Microbial flora of the normal esophagus. Dis Esophagus. 1998;11(4):248–250. doi: 10.1093/dote/11.4.248.
   PubMedGoogle Scholar
• Pei Z, Bini EJ, Yang L, et al. Bacterial biota in the human distal esophagus. Proc Natl Acad Sci U S A. 2004;101(12):4250–4255. doi: 10.1073/pnas.0306398101.
   PubMed Web of Science ®Google Scholar
• Blackett KL, Siddhi SS, Cleary S, et al. Oesophageal bacterial biofilm changes in gastro-oesophageal reflux disease, barrett’s and oesophageal carcinoma: association or causality? Aliment Pharmacol Ther. 2013;37(11):1084–1092. doi: 10.1111/apt.12317.
   PubMed Web of Science ®Google Scholar
• Elliott DRF, Walker AW, O’Donovan M, et al. A non-endoscopic device to sample the oesophageal microbiota: a case-control study. Lancet Gastroenterol Hepatol. 2017;2(1):32–42. doi: 10.1016/S2468-1253(16)30086-3.
   PubMed Web of Science ®Google Scholar
• Verma D, Garg PK, Dubey AK. Insights into the human oral microbiome. Arch Microbiol. 2018;200(4):525–540. doi: 10.1007/s00203-018-1505-3.
   PubMed Web of Science ®Google Scholar
• Yang L, Lu X, Nossa CW, et al. Inflammation and intestinal metaplasia of the distal esophagus are associated with alterations in the microbiome. Gastroenterology. 2009;137(2):588–597. doi: 10.1053/j.gastro.2009.04.046.
   PubMed Web of Science ®Google Scholar
• Yu G, Gail MH, Shi J, et al. Association between upper digestive tract microbiota and cancer-predisposing states in the esophagus and stomach. Cancer Epidemiol Biomarkers Prev. 2014;23(5):735–741. doi: 10.1158/1055-9965.EPI-13-0855.
   PubMed Web of Science ®Google Scholar
• Yang W, Chen CH, Jia M, et al. Tumor-Associated microbiota in esophageal squamous cell carcinoma. Front Cell Dev Biol. 2021;9:641270. doi: 10.3389/fcell.2021.641270.
   PubMed Web of Science ®Google Scholar
• Glenn TF, Esophageal C Facts, figures, and screening. Gastroenterol Nurs. 2001;24(6):271–273. quiz 274-275. doi: 10.1097/00001610-200111000-00002.
   PubMedGoogle Scholar
• Shao D, Vogtmann E, Liu A, et al. Microbial characterization of esophageal squamous cell carcinoma and gastric cardia adenocarcinoma from a high-risk region of China. Cancer. 2019;125(22):3993–4002. doi: 10.1002/cncr.32403.
   PubMed Web of Science ®Google Scholar
• Cho I, Blaser MJ. The human microbiome: at the interface of health and disease. Nat Rev Genet. 2012;13(4):260–270. doi: 10.1038/nrg3182.
   PubMed Web of Science ®Google Scholar
• Yamamura K, Baba Y, Miyake K, et al. Fusobacterium nucleatum in gastroenterological cancer: evaluation of measurement methods using quantitative polymerase chain reaction and a literature review. Oncol Lett. 2017;14(6):6373–6378. doi: 10.3892/ol.2017.7001.
   PubMed Web of Science ®Google Scholar
• Hajishengallis G, Darveau RP, Curtis MA. The keystone-pathogen hypothesis. Nat Rev Microbiol. 2012;10(10):717–725. doi: 10.1038/nrmicro2873.
   PubMed Web of Science ®Google Scholar
• Hajishengallis G, Lamont RJ. Dancing with the stars: how choreographed bacterial interactions dictate nososymbiocity and give rise to keystone pathogens, accessory pathogens, and pathobionts. Trends Microbiol. 2016;24(6):477–489. doi: 10.1016/j.tim.2016.02.010.
   PubMed Web of Science ®Google Scholar
• Olsen I. From the acta prize lecture 2014: the periodontal-systemic connection seen from a microbiological standpoint. Acta Odontol Scand. 2015;73(8):563–568. doi: 10.3109/00016357.2015.1007480.
   PubMed Web of Science ®Google Scholar
• Atanasova KR, Yilmaz O. Prelude to oral microbes and chronic diseases: past, present and future. Microbes Infect. 2015;17(7):473–483. doi: 10.1016/j.micinf.2015.03.007.
   PubMed Web of Science ®Google Scholar
• Dominy SS, Lynch C, Ermini F, et al. Porphyromonas gingivalis in Alzheimer’s disease brains: evidence for disease causation and treatment with small-molecule inhibitors. Sci Adv. 2019;5(1):eaau3333. doi: 10.1126/sciadv.aau3333.
   PubMed Web of Science ®Google Scholar
• Sayehmiri F, Sayehmiri K, Asadollahi K, et al. The prevalence rate of Porphyromonas gingivalis and its association with cancer: a systematic review and meta-analysis. Int J Immunopathol Pharmacol. 2015;28(2):160–167. doi: 10.1177/0394632015586144.
   PubMed Web of Science ®Google Scholar
• Gao SG, Yang JQ, Ma ZK, et al. Preoperative serum immunoglobulin G and a antibodies to Porphyromonas gingivalis are potential serum biomarkers for the diagnosis and prognosis of esophageal squamous cell carcinoma. BMC Cancer. 2018;18(1):17. doi: 10.1186/s12885-017-3905-1.
   PubMedGoogle Scholar
• Williams MP, Pounder RE. Helicobacter pylori: from the benign to the malignant. Am J Gastroenterol. 1999;94(11 Suppl):S11–S16. doi: 10.1016/s0002-9270(99)00657-7.
   PubMed Web of Science ®Google Scholar
• Sheh A, Fox JG. The role of the gastrointestinal microbiome in Helicobacter pylori pathogenesis. Gut Microbes. 2013;4(6):505–531. doi: 10.4161/gmic.26205.
   PubMed Web of Science ®Google Scholar
• Bik EM, Eckburg PB, Gill SR, et al. Molecular analysis of the bacterial microbiota in the human stomach. Proc Natl Acad Sci USA. 2006;103(3):732–737. doi: 10.1073/pnas.0506655103.
   PubMed Web of Science ®Google Scholar
• Delgado S, Cabrera-Rubio R, Mira A, et al. Microbiological survey of the human gastric ecosystem using culturing and pyrosequencing methods. Microb Ecol. 2013;65(3):763–772. doi: 10.1007/s00248-013-0192-5.
   PubMed Web of Science ®Google Scholar
• Nasrollahzadeh D, Malekzadeh R, Ploner A, et al. Variations of gastric corpus microbiota are associated with early esophageal squamous cell carcinoma and squamous dysplasia. Sci Rep. 2015;5(1):8820. doi: 10.1038/srep08820.
   PubMedGoogle Scholar
• Yu G, Torres J, Hu N, et al. Molecular characterization of the human stomach microbiota in gastric cancer patients. Front Cell Infect Microbiol. 2017;7:302. doi: 10.3389/fcimb.2017.00302.
   PubMed Web of Science ®Google Scholar
• Yu G, Hu N, Wang L, et al. Gastric microbiota features associated with cancer risk factors and clinical outcomes: a pilot study in gastric cardia cancer patients from shanxi, China. Int J Cancer. 2017;141(1):45–51. doi: 10.1002/ijc.30700.
   PubMed Web of Science ®Google Scholar
• Plummer M, de Martel C, Vignat J, et al. Global burden of cancers attributable to infections in 2012: a synthetic analysis. Lancet Glob Health. 2016;4(9):e609–616. doi: 10.1016/S2214-109X(16)30143-7.
   PubMed Web of Science ®Google Scholar
• Syrjänen KJ. HPV infections and oesophageal cancer. J Clin Pathol. 2002;55(10):721–728.
   PubMed Web of Science ®Google Scholar
• Syrjänen K. Geographic origin is a significant determinant of human papillomavirus prevalence in oesophageal squamous cell carcinoma: systematic review and meta-analysis. Scand J Infect Dis. 2013;45(1):1–18. doi: 10.3109/00365548.2012.702281.
   PubMed Web of Science ®Google Scholar
• Zhang SK, Guo LW, Chen Q, et al. Prevalence of human papillomavirus 16 in esophageal cancer among the chinese population: a systematic review and meta-analysis. Asian Pac J Cancer Prev. 2014;15(23):10143–10149. doi: 10.7314/apjcp.2014.15.23.10143.
   PubMedGoogle Scholar
• Hošnjak L, Poljak M. A systematic literature review of studies reporting human papillomavirus (HPV) prevalence in esophageal carcinoma over 36 years (1982-2017). Acta Dermatovenerologica Alpina, Pannonica, et Adriatica. 2018;27(3):127–136.
   PubMedGoogle Scholar
• Petrick JL, Wyss AB, Butler AM, et al. Prevalence of human papillomavirus among oesophageal squamous cell carcinoma cases: systematic review and meta-analysis. Br J Cancer. 2014;110(9):2369–2377. doi: 10.1038/bjc.2014.96.
   PubMed Web of Science ®Google Scholar
• Yahyapour Y, Rahmani R, Alipour M, et al. Prevalence and association of human papillomavirus, Epstein-Barr virus and merkel cell polyomavirus with neoplastic esophageal lesions in Northern Iran. Caspian J Intern Med. 2018;9(4):353–360.
   PubMedGoogle Scholar
• Yong F, Xudong N, Lijie T. Human papillomavirus types 16 and 18 in esophagus squamous cell carcinoma: a meta-analysis. Ann Epidemiol. 2013;23(11):726–734. doi: 10.1016/j.annepidem.2013.07.002.
   PubMed Web of Science ®Google Scholar
• Guo LW, Zhang SK, Liu SZ, et al. Human papillomavirus type-18 prevalence in oesophageal cancer in the chinese population: a meta-analysis. Epidemiol Infect. 2016;144(3):469–477. doi: 10.1017/S0950268815001703.
   PubMed Web of Science ®Google Scholar
• Guo F, Liu Y, Wang X, et al. Human papillomavirus infection and esophageal squamous cell carcinoma: a case-control study. Cancer Epidemiol Biomarkers Prev. 2012;21(5):780–785. doi: 10.1158/1055-9965.EPI-11-1206.
   PubMed Web of Science ®Google Scholar
• Liyanage SS, Rahman B, Ridda I, et al. The aetiological role of human papillomavirus in oesophageal squamous cell carcinoma: a meta-analysis. PLoS One. 2013;8(7):e69238. doi: 10.1371/journal.pone.0069238.
   PubMed Web of Science ®Google Scholar
• Li S, Shen H, Li J, et al. Prevalence of the integration status for human papillomavirus 16 in esophageal carcinoma samples. Turk J Gastroenterol. 2018;29(2):157–163. doi: 10.5152/tjg.2018.17568.
   PubMed Web of Science ®Google Scholar
• Koshiol J, Wei WQ, Kreimer AR, et al. No role for human papillomavirus in esophageal squamous cell carcinoma in China. Int J Cancer. 2010;127(1):93–100. doi: 10.1002/ijc.25023.
   PubMed Web of Science ®Google Scholar
• Agalliu I, Chen Z, Wang T, et al. Oral alpha, beta, and gamma HPV types and risk of incident esophageal cancer. Cancer Epidemiol Biomarkers Prev. 2018;27(10):1168–1175. doi: 10.1158/1055-9965.EPI-18-0287.
   PubMed Web of Science ®Google Scholar
• Sitas F, Egger S, Urban MI, et al. InterSCOPE study: Associations between esophageal squamous cell carcinoma and human papillomavirus serological markers. J Natl Cancer Inst. 2012;104(2):147–158. doi: 10.1093/jnci/djr499.
   PubMedGoogle Scholar
• Kanaan C, Lorenzo D, Barret M, et al. Early esophageal squamous cell carcinoma in a Western series is not associated with active HPV infection. Virchows Arch. 2020;477(5):697–704. doi: 10.1007/s00428-020-02860-2.
   PubMed Web of Science ®Google Scholar
• Network. CGAR. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017;541(7636):169–175.
   PubMed Web of Science ®Google Scholar
• Liu W, Snell JM, Jeck WR, et al. Subtyping Sub-Saharan esophageal squamous cell carcinoma by comprehensive molecular analysis. JCI Insight. 2016;1(16):e88755. doi: 10.1172/jci.insight.88755.
   PubMed Web of Science ®Google Scholar
• Stanfield BA, Luftig MA. Recent advances in understanding Epstein-Barr virus. F1000Res. 2017;6:386. doi: 10.12688/f1000research.10591.1.
   PubMedGoogle Scholar
• Young LS, Rickinson AB. Epstein-Barr virus: 40 years on. Nat Rev Cancer. 2004;4(10):757–768. doi: 10.1038/nrc1452.
   PubMed Web of Science ®Google Scholar
• El-Zimaity H, Di Pilato V, Novella Ringressi M, et al. Risk factors for esophageal cancer: emphasis on infectious agents. Ann N Y Acad Sci. 2018;1434(1):319–332. doi: 10.1111/nyas.13858.
   PubMed Web of Science ®Google Scholar
• Xu W, Liu Z, Bao Q, et al. Viruses, other pathogenic microorganisms and esophageal cancer. Gastrointest Tumors. 2015;2(1):2–13. doi: 10.1159/000380897.
   PubMedGoogle Scholar
• Jenkins TD, Nakagawa H, Rustgi AK. The association of Epstein-Barr virus DNA with esophageal squamous cell carcinoma. Oncogene. 1996;13(8):1809–1813.
   PubMed Web of Science ®Google Scholar
• Hewitt LC, Inam IZ, Saito Y, et al. Epstein-Barr virus and mismatch repair deficiency status differ between oesophageal and gastric cancer: a large multi-Centre study. Eur J Cancer. 2018;94:104–114. doi: 10.1016/j.ejca.2018.02.014.
   PubMed Web of Science ®Google Scholar
• Chang F, Syrjänen S, Shen Q, et al. Evaluation of HPV, CMV, HSV and EBV in esophageal squamous cell carcinomas from a high-incidence area of China. Anticancer Research. 2000;20(5c):3935–3940.
   PubMed Web of Science ®Google Scholar
• Yahyapour Y, Sadeghi F, Alizadeh A, et al. Detection of merkel cell polyomavirus and human papillomavirus in esophageal squamous cell carcinomas and non-Cancerous esophageal samples in Northern Iran. Pathol Oncol Res. 2016;22(4):667–672. doi: 10.1007/s12253-016-0048-7.
   PubMed Web of Science ®Google Scholar
• Del Valle L, White MK, Enam S, et al. Detection of JC virus DNA sequences and expression of viral T antigen and agnoprotein in esophageal carcinoma. Cancer. 2005;103(3):516–527. doi: 10.1002/cncr.20806.
   PubMed Web of Science ®Google Scholar
• Wu MY, Wu XY, Zhuang CX. Detection of HSV and EBV in esophageal carcinomas from a high-incidence area in Shantou China. Dis Esophagus. 2005;18(1):46–50. doi: 10.1111/j.1442-2050.2005.00423.x.
   PubMed Web of Science ®Google Scholar
• Zhang DH, Zhang QY, Hong CQ, et al. Prevalence and association of human papillomavirus 16, Epstein-Barr virus, herpes simplex virus-1 and cytomegalovirus infection with human esophageal carcinoma: a case-control study. Oncology Reports. 2011;25(6):1731–1738.
   PubMed Web of Science ®Google Scholar
• Poore GD, Kopylova E, Zhu Q, et al. Microbiome analyses of blood and tissues suggest cancer diagnostic approach. Nature. 2020;579(7800):567–574. doi: 10.1038/s41586-020-2095-1.
   PubMed Web of Science ®Google Scholar
• El Tekle G, Garrett WS. Bacteria in cancer initiation, promotion and progression. Nat Rev Cancer. 2023;23(9):600–618. doi: 10.1038/s41568-023-00594-2.
   PubMed Web of Science ®Google Scholar
• Reyes L. Porphyromonas gingivalis. Trends Microbiol. 2021;29(4):376–377. doi: 10.1016/j.tim.2021.01.010.
   PubMed Web of Science ®Google Scholar
• Whitmore SE, Lamont RJ. Oral bacteria and cancer. PLoS Pathog. 2014;10(3):e1003933. doi: 10.1371/journal.ppat.1003933.
   PubMed Web of Science ®Google Scholar
• Chen MF, Lu MS, Hsieh CC, et al. Porphyromonas gingivalis promotes tumor progression in esophageal squamous cell carcinoma. Cell Oncol (Dordr). 2021;44(2):373–384. doi: 10.1007/s13402-020-00573-x.
   PubMed Web of Science ®Google Scholar
• Gao S, Liu K, Jiao Y, et al. Selective activation of TGFβ signaling by P. gingivalis-mediated upregulation of GARP aggravates esophageal squamous cell carcinoma. Am J Cancer Res. 2023;13(5):2013–2029.
   PubMed Web of Science ®Google Scholar
• Wang X, Jia Y, Wen L, et al. Porphyromonas gingivalis promotes colorectal carcinoma by activating the hematopoietic NLRP3 inflammasome. Cancer Res. 2021;81(10):2745–2759. doi: 10.1158/0008-5472.CAN-20-3827.
   PubMed Web of Science ®Google Scholar
• Yuan X, Liu Y, Li G, et al. Blockade of immune-Checkpoint B7-H4 and lysine demethylase 5B in esophageal squamous cell carcinoma confers protective immunity against P. gingivalis infection. Cancer Immunol Res. 2019;7(9):1440–1456. doi: 10.1158/2326-6066.CIR-18-0709.
   PubMed Web of Science ®Google Scholar
• Geller LT, Barzily-Rokni M, Danino T, et al. Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine. Science. 2017;357(6356):1156–1160. doi: 10.1126/science.aah5043.
   PubMed Web of Science ®Google Scholar
• Routy B, Le Chatelier E, Derosa L, et al. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science. 2018;359(6371):91–97. doi: 10.1126/science.aan3706.
   PubMed Web of Science ®Google Scholar
• Gao S, Liu Y, Duan X, et al. Porphyromonas gingivalis infection exacerbates oesophageal cancer and promotes resistance to neoadjuvant chemotherapy. Br J Cancer. 2021;125(3):433–444. doi: 10.1038/s41416-021-01419-5.
   PubMed Web of Science ®Google Scholar
• Liang G, Wang H, Shi H, et al. Porphyromonas gingivalis promotes the proliferation and migration of esophageal squamous cell carcinoma through the miR-194/GRHL3/PTEN/akt axis. ACS Infect Dis. 2020;6(5):871–881. doi: 10.1021/acsinfecdis.0c00007.
   PubMed Web of Science ®Google Scholar